Elsevier

Value in Health

Volume 19, Issue 7, November 2016, Page A594
Value in Health

PSY110 - Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis: 4-Year Outcomes from the Rapid-Psa Study

https://doi.org/10.1016/j.jval.2016.09.1426Get rights and content
Under an Elsevier user license
open archive

Cited by (0)